Multitude Therapeutics
Biotechnology Research
Redwood City, California, United States
7 employees
- Employees
- 7
Multitude Therapeutics Overview
- Headquarters
- Redwood City, California, United States
- Website
- www.multitudetherapeutics.info
- Industry
- Biotechnology Research
- Employees
- 7
- Founded
- 2018
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Multitude Therapeutics
Multitude Therapeutics (MTX) is a spinoff company created by Abmart to leverage its unparalleled target and antibody discovery capability for cancer immunotherapy. MTX focuses on developing novel antibody-drug conjugates (ADC), CAR-Ts and immuno-oncology antibodies for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer and immune cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart.
Compare Similar Companies to Multitude Therapeutics
IRBM
Biotechnology Research
Ambrx
Biotechnology Research
Adcendo
Biotechnology Research
MediLink Therapeutics
Biotechnology Research
Lepu Biopharma Co., Ltd
Pharmaceutical Manufacturing
Solve Therapeutics, Inc.
Biotechnology Research
Tavotek Biotherapeutics
Pharmaceutical Manufacturing
LaNova Medicines
Biotechnology
Precision Biologics, Inc.
Biotechnology Research
Foreseen Biotechnology
Biotechnology Research